The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 08, 2017

Filed:

Oct. 21, 2015
Applicant:

Sciclone Pharmaceuticals, Inc., Foster City, CA (US);

Inventors:

Robert S. King, Fremont, CA (US);

Cynthia W. Tuthill, Hercules, CA (US);

Friedhelm Blobel, Foster City, CA (US);

Assignee:

SciClone Pharmaceuticals, Inc., Foster City, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/22 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); A61K 31/44 (2006.01); A61K 31/165 (2006.01); C07K 16/28 (2006.01); A61K 31/655 (2006.01); A61K 38/19 (2006.01); A61K 38/20 (2006.01); A61K 38/21 (2006.01);
U.S. Cl.
CPC ...
A61K 38/2292 (2013.01); A61K 31/165 (2013.01); A61K 31/44 (2013.01); A61K 31/655 (2013.01); A61K 38/193 (2013.01); A61K 38/2046 (2013.01); A61K 38/21 (2013.01); A61K 39/39558 (2013.01); A61K 45/06 (2013.01); C07K 16/2818 (2013.01); C07K 2317/70 (2013.01);
Abstract

The present invention provides compositions and methods for treating cancer or a metastasis thereof in a subject. In some embodiments, the methods involve administering a composition comprising therapeutically effective amount of at least one immune stimulator to the subject. In some embodiments, a combination of at least two immune stimulators is used for the treatment. In some embodiments, the combination includes an alpha thymosin peptide and an additional immune stimulator, and/or optionally one or more additional anti-cancer agents.


Find Patent Forward Citations

Loading…